Matthew R. Henn, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 89 shares at $8.47 ($754) on 2026-02-15, disclosed to the SEC on 2026-02-18.
Open-market sale of $754 MCRB by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MCRB | SELL | 2025-11-18 | $22K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $1K | — | Filing → |
| MCRB | SELL | 2025-05-19 | $561 | — | Filing → |